Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Reddit Emerges as a Major Winner in the Shift to AI-Powered Search 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
 shares announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, March 14, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain purchasers of shares of Omega Protein Corporation (NYSE:OME) over alleged Securities Laws Violations by Omega Protein Corporation.
Investors, who purchased shares of Omega Protein Corporation (NYSE:OME), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects, including: that Omega Protein’s subsidiary was potentially not in compliance with its probation terms, that the Company was not properly protecting whistleblower employees, that, as a result of the foregoing, the Company was vulnerable to an SEC investigation and potential civil and criminal liability, and that, as a result of the foregoing, Defendants’ statements about Omega Protein’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On March 1, 2017, Omega Protein Corporation disclosed that in December 2016 it had received a subpoena from the Securities and Exchange Commission (“SEC”) seeking information in connection with an investigation of an Omega Protein Corporation subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees.
Those who purchased Omega Protein Corporation (NYSE: OME) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
